Does REPAGLINIDE Cause Agranulocytosis? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Agranulocytosis have been filed in association with REPAGLINIDE (Repaglinide). This represents 1.3% of all adverse event reports for REPAGLINIDE.
33
Reports of Agranulocytosis with REPAGLINIDE
1.3%
of all REPAGLINIDE reports
0
Deaths
30
Hospitalizations
How Dangerous Is Agranulocytosis From REPAGLINIDE?
Of the 33 reports, 30 (90.9%) required hospitalization, and 2 (6.1%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REPAGLINIDE. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does REPAGLINIDE Cause?
Hypoglycaemia (665)
Acute kidney injury (281)
Lactic acidosis (163)
Hypoglycaemic coma (125)
Sopor (91)
Confusional state (89)
Drug interaction (89)
Blood glucose increased (88)
Diarrhoea (87)
Dyspnoea (87)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which REPAGLINIDE Alternatives Have Lower Agranulocytosis Risk?
REPAGLINIDE vs REPOTRECTINIB
REPAGLINIDE vs REQUIP
REPAGLINIDE vs RESLIZUMAB
REPAGLINIDE vs RESMETIROM
REPAGLINIDE vs RESTASIS